Malignant hypertension natural history, complications and prognosis: Difference between revisions
Created page with "__NOTOC__ {{Malignant hypertension}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References==..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Malignant hypertension}} | {{Malignant hypertension}} | ||
{{CMG}} | |||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
==Prognosis== | |||
Prior to effective therapy, life expectancy was less than 2 years, with most deaths resulting from [[stroke]], renal failure, or[[heart]] failure. The survival rate at 1 year was less than 25% and at 5 years was less than 1%. With current therapy, including dialysis, the survival rate at 1 year is greater than 90% and at 5 years is 80%. The most common cause of death is cardiac, with stroke and renal failure also common. The single greatest prognostic factor in malignant hypertension is renal function, with renal insufficiency secondary to malignant nephrosclerosis being strongly associated with poorer outcomes. | |||
==References== | ==References== | ||
Revision as of 19:55, 22 February 2013
|
Malignant hypertension Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Malignant hypertension natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Malignant hypertension natural history, complications and prognosis |
|
FDA on Malignant hypertension natural history, complications and prognosis |
|
CDC on Malignant hypertension natural history, complications and prognosis |
|
Malignant hypertension natural history, complications and prognosis in the news |
|
Blogs on Malignant hypertension natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Prognosis
Prior to effective therapy, life expectancy was less than 2 years, with most deaths resulting from stroke, renal failure, orheart failure. The survival rate at 1 year was less than 25% and at 5 years was less than 1%. With current therapy, including dialysis, the survival rate at 1 year is greater than 90% and at 5 years is 80%. The most common cause of death is cardiac, with stroke and renal failure also common. The single greatest prognostic factor in malignant hypertension is renal function, with renal insufficiency secondary to malignant nephrosclerosis being strongly associated with poorer outcomes.